Top Markets
Coin of the day
Idogen AB (publ) Idogen AB (publ)

Idogen AB (publ)

IDOGEN
Pozycja w akcjach #37811
Idogen AB (publ) is a Swedish biotechnology company specializing in the... Idogen AB (publ) is a Swedish biotechnology company specializing in the development of tolerogenic cell therapies. These innovative treatments are engineered to prevent a patient's immune system from attacking crucial elements, including biological agents, transplanted organs, and the body's own cells or tissues. The company's most advanced product in development is IDO 8, designed for individuals with severe haemophilia A who have developed neutralizing antibodies against their vital coagulation factor VIII treatment. Idogen is also developing IDO T, a tolerogenic cell therapy intended to prevent organ transplant rejection, primarily for kidney transplants, and IDO AID, aimed at treating autoimmune diseases. Established in 2008, the company is headquartered in Lund, Sweden.
Cena akcji
$0.01345907
Ostatnia synchronizacja: 2024-07-12
Kapitalizacja rynkowa
$1.43M
Zmiana (1 dzień)
22.16%
Zmiana (1 rok)
0.00%
Kraj
SE
Handel Idogen AB (publ) (IDOGEN)

Kategoria

Historia ceny akcji dla Idogen AB (publ) (IDOGEN)
Najwyższa cena zamknięcia: $0.01 dnia 2024-07-01

Najniższa cena zamknięcia: $6.87 dnia 2015-06-01
Historia cen akcji firmy Idogen AB (publ) od 2015 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2024 17.75%
2023 -33.56%
2022 -90.58%
2021 -53.76%
2020 -45.68%
2019 -53.15%
2018 -66.56%
2017 -52.66%
2016 54.52%
2015 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE